Jefferies Upgrades Arteris to Buy, Raises Price Target to $50
Jefferies analyst Kevin Garrigan upgrades Arteris (NASDAQ:AIP) from Hold to Buy and raises the price target from $35 to $50.
Stocks · News reference
U.S. stocks traded higher on Thursday, with the Dow up 0.72%, NASDAQ down 0.90%, and S&P 500 down 0.22%. Health care shares jumped 2.2%.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Jefferies analyst Kevin Garrigan upgrades Arteris (NASDAQ:AIP) from Hold to Buy and raises the price target from $35 to $50.
Arteris (NASDAQ:AIP) sees Q3 sales of $24.000 million-$25.000 million vs $23.415 million analyst estimate.
Arteris (NASDAQ:AIP) raises FY2026 sales outlook from $91.000 million-$95.000 million to $95.000 million-$98.000 million vs $94.578 million estimate.
Arteris (NASDAQ:AIP) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.04) by 150 percent. This is a 9.09 percent increase over losses of $(0.11) per share from the same
Filed: 2026-08-27 AccNo: 0001627282-26-000067 Size: 251 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Caliber (Nasdaq: CWD), a real estate-focused alternative asset manager, today announced the formation of Caliber Tokenization Services, LLC ("CTS"), a new division that provides full-service real-world asset